CELESTIAL THERAPEUTICS

Website

CELESTIAL THERAPEUTICS INC.

5 Investors
Biopharmaceuticals
IRVINE, CA

Celestial Therapeutics Inc. is a biopharmaceutical company dedicated to developing innovative therapies aimed at treating, preventing, and curing infectious diseases, inflammatory conditions, and various forms of cancer. With a strong focus on addressing key unmet medical needs, the company integrates cutting-edge technology into its therapeutic solutions.

Products & Team

CT-02

TherapeuticsSeed

CT-02 is a first-in-class broad-spectrum anti-infective and anti-inflammatory drug primarily developed for the treatment of respiratory syncytial virus (RSV). It represents a significant advancement in the realm of infectious disease management by providing effective treatment options for viral infections.

Value Proposition

The drug aims to significantly improve the therapeutic outcomes for patients suffering from RSV by providing an innovative treatment option that addresses both infection and inflammation.

Pain Points

Celestial Therapeutics addresses critical issues such as the need for effective treatments for RSV, innovative therapies for inflammatory disorders, and advanced cancer treatments that meet the demand for safer and more effective therapeutic options.

Broad-spectrum activity against multiple pathogensDual action as anti-infective and anti-inflammatoryTargeted initially at respiratory viral infections
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
IRVINE, CA
Primary headquarters

Funding History

0
E

Equity Offering

September 2024
Unknown Amount
No Funding Limit
E

Equity Offering

September 2024
Unknown Amount
No Funding Limit
E

Equity Offering

April 2025
Unknown Amount
No Funding Limit
E

Equity Offering

April 2025
Unknown Amount
No Funding Limit